// App-Quantinova.ai

4848 : Discovery of ABI-231 analogs targeting the colchicine site in tubulin for advanced melanoma

Researchers

Presenter

  • Wang Qinghui

Principal Investigators

  • Arnst E. Kinsie

  • Duane D. Miller

  • Wei Li

Medical Centers

  • The University of Tennessee Health Science Center, Memphis, TN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

  • Phosphatase and tensin homolog

  • Cyclin Dependent Kinase Inhibitor 2A

  • Tumor protein p53

Drug/Treatment

  • Colchicine

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved